Santen Pharmaceutical Co., Ltd. Share Price Börse Stuttgart
Stocks
SZD
JP3336000009
Pharmaceuticals
OTC Markets Traded|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 10.50 EUR | +0.96% |
|
+10.30% | +10.30% |
| 08-06 | Santen Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended June 30, 2026 | CI |
| 07-27 | Glaukos' Trial of Preserflo MicroShunt Completes Enrollment | MT |
| Market Cap | 624B 3.92B 3.4B 3.18B 2.9B 5.46B 374B 5.55B 37.27B 14.6B 187B 14.71B 14.39B | P/E 2027 * |
15.9x | P/E 2028 * | 15x |
|---|---|---|---|---|---|
| Enterprise Value | 585B 3.68B 3.19B 2.98B 2.72B 5.12B 351B 5.21B 34.96B 13.7B 175B 13.8B 13.5B | EV / Sales 2027 * |
1.93x | EV / Sales 2028 * | 1.75x |
| Free-Float |
96.71% | Yield 2027 * |
2.16% | Yield 2028 * | 2.42% |
| 29/09/23 | ETF der Woche: Back to the Roots | |
| 28/09/23 | ETF van de week: terug naar de basis | |
| 28/09/23 | L'ETF della settimana: ritorno ai fondamentali | |
| 28/09/23 | ETF de la semaine : Retour aux fondamentaux | |
| 15/02/21 | Nicox S A : A suivre aujourd'hui |
| 1 week | +0.96% | ||
| Current month | +3.96% | ||
| 1 month | -8.70% | ||
| 3 months | +20.00% | ||
| 6 months | +13.51% | ||
| Current year | +20.69% |
| 1 week | 10 |  | 10.7 |
| 1 month | 9.95 | | 11.6 |
| 3 years | 7.8 | | 12 |
| 5 years | 6.4 | | 13 |
| Manager | Title | Age | Since |
|---|---|---|---|
Takeshi Ito
CEO | Chief Executive Officer | 67 | 31/08/2022 |
Kazuo Koshiji
DFI | Director of Finance/CFO | - | - |
Daisuke Nakata
CTO | Chief Tech/Sci/R&D Officer | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
Takeshi Ito
BRD | Director/Board Member | 67 | 22/06/2017 |
Ippei Kurihara
BRD | Director/Board Member | 45 | 31/05/2024 |
Rie Nakajima
BRD | Director/Board Member | 48 | 31/05/2024 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.96% | +10.30% | +20.00% | +27.27% | 3.93B | |
| -1.37% | +8.90% | +91.28% | +130.00% | 1,098B | |
| -0.77% | +1.91% | +49.46% | +49.44% | 631B | |
| +0.85% | +2.58% | +25.90% | +64.34% | 438B | |
| -1.13% | +3.13% | +49.78% | +39.13% | 368B | |
| -0.74% | +1.01% | +31.08% | +38.64% | 298B | |
| -1.22% | +0.89% | +7.32% | +7.38% | 251B | |
| -0.70% | +6.23% | +45.32% | +57.82% | 226B | |
| +0.34% | -0.13% | -4.77% | -50.50% | 209B | |
| +2.04% | +0.38% | +12.70% | +69.71% | 165B | |
| Average | -0.30% | +1,662.58% | +32.81% | +43.32% | 409.37B | |
| Weighted average by Cap. | -0.63% | +1,339.54% | +49.78% | +66.15% |
| 2027 * | 2028 * | |
|---|---|---|
| Net sales | 303B 1.9B 1.65B 1.54B 1.41B 2.65B 181B 2.69B 18.08B 7.08B 90.74B 7.14B 6.98B | 312B 1.96B 1.7B 1.59B 1.45B 2.73B 187B 2.78B 18.64B 7.3B 93.55B 7.36B 7.2B |
| Net income | 38.46B 241M 209M 196M 179M 336M 23.03B 342M 2.3B 900M 11.53B 907M 887M | 41.32B 259M 225M 210M 192M 361M 24.75B 367M 2.47B 967M 12.39B 974M 953M |
| Net Debt | -38.7B -243M -211M -197M -180M -338M -23.18B -344M -2.31B -906M -11.6B -912M -892M | -76.67B -481M -417M -391M -356M -671M -45.91B -682M -4.58B -1.79B -22.98B -1.81B -1.77B |
| Date | Price | Change |
|---|---|---|
| 11/08/26 | €10.50 | +0.96% |
| 10/08/26 | €10.40 | -1.89% |
| 07/08/26 | €10.60 | +4.95% |
| 06/08/26 | €10.10 | +1.00% |
| 05/08/26 | €10.00 | -3.85% |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- 4536 Stock
- SZD Stock
Select your edition
All financial news and data tailored to specific country editions
